Next-generation ARIA care pathways for rhinitis and asthma: a model for multimorbid chronic diseases
Status PubMed-not-MEDLINE Language English Country Great Britain, England Media electronic-ecollection
Document type Journal Article, Review
Grant support
001
World Health Organization - International
PubMed
31516692
PubMed Central
PMC6734297
DOI
10.1186/s13601-019-0279-2
PII: 279
Knihovny.cz E-resources
- Keywords
- ARIA, Care pathways, Health care transformation, MASK, POLLAR, Rhinitis,
- Publication type
- Journal Article MeSH
- Review MeSH
BACKGROUND: In all societies, the burden and cost of allergic and chronic respiratory diseases are increasing rapidly. Most economies are struggling to deliver modern health care effectively. There is a need to support the transformation of the health care system into integrated care with organizational health literacy. MAIN BODY: As an example for chronic disease care, MASK (Mobile Airways Sentinel NetworK), a new project of the ARIA (Allergic Rhinitis and its Impact on Asthma) initiative, and POLLAR (Impact of Air POLLution on Asthma and Rhinitis, EIT Health), in collaboration with professional and patient organizations in the field of allergy and airway diseases, are proposing real-life ICPs centred around the patient with rhinitis, and using mHealth to monitor environmental exposure. Three aspects of care pathways are being developed: (i) Patient participation, health literacy and self-care through technology-assisted "patient activation", (ii) Implementation of care pathways by pharmacists and (iii) Next-generation guidelines assessing the recommendations of GRADE guidelines in rhinitis and asthma using real-world evidence (RWE) obtained through mobile technology. The EU and global political agendas are of great importance in supporting the digital transformation of health and care, and MASK has been recognized by DG Santé as a Good Practice in the field of digitally-enabled, integrated, person-centred care. CONCLUSION: In 20 years, ARIA has considerably evolved from the first multimorbidity guideline in respiratory diseases to the digital transformation of health and care with a strong political involvement.
1st Department of Family Medicine Medical University of Lodz Łódź Poland
Academic Centre of Primary Care University of Aberdeen Aberdeen Scotland UK
Academic Medical Center Univ of Amsterdam Amsterdam The Netherlands
Allergy and Asthma Associates of Southern California Mission Viejo CA USA
Allergy and Asthma Center Westend Berlin Germany
Allergy and Asthma Medical Group and Research Center San Diego CA USA
Allergy and Asthma Unit Hospital San Bernardo Salta Salta Argentina
Allergy and Respiratory Research Group The University of Edinburgh Edinburgh UK
Allergy Center CUF Descobertas Hospital Lisbon Portugal
Allergy Department Pasteur Institute Paris France
Allergy Service University Hospital of Federal University of Santa Catarina Florianópolis Brazil
Allergy Unit CUF Porto Hospital and Institute Porto Portugal
Allergy Unit Department of Dermatology University Hospital of Zurich Zurich Switzerland
Allergy Unit Presidio Columbus Catholic University of Sacred Heart Rome Italy
Argentine Association of Allergy and Clinical Immunology Buenos Aires Argentina
ASA Advanced Solutions Accelerator Clapiers France
Association Asthme et Allergie Paris France
Association of Finnish Pharmacists Helsinki Finland
Asthma UK Mansell Street London UK
Cáritas Diocesana de Coimbra Coimbra Portugal
Center for Allergy and Immunology Santa Fe Argentina
Center for Rhinology and Allergology Wiesbaden Germany
Center of Allergy Immunology and Respiratory Diseases Santa Fe Argentina
Centre for Clinical Research Sörmland Uppsala University Eskilstuna Sweden
Centre for Empowering Patients and Communities Faulkland Somerset UK
Centre Hospitalier Universitaire Pédiatrique Charles de Gaulle Ouagadougou Burkina Faso
Children's Hospital Srebrnjak Zagreb Croatia
CIBER Epidemiología y Salud Pública Barcelona Spain
CIRFF Federico 2 University Naples Italy
Clinic of Children's Diseases Faculty of Medicine Vilnius University Vilnius Lithuania
Clinic of Infectious Chest Diseases Dermatology and Allergology Vilnius University Vilnius Lithuania
Clinical Medicine Laval's University Quebec City Canada
Clinical Reserch Center for Allergy and Rheumatology Sagamihara National Hospital Sagamihara Japan
CNR Institute of Biomedicine and Molecular Immunology A Monroy Palermo Italy
Conseil Général de l'Economie Ministère de l'Economie de l'Industrie et du Numérique Paris France
Consortium of Pharmacies and Services COSAFER Salerno Italy
CRI Clinical Research International Ltd Hamburg Germany
Croatian Pulmonary Society Zagreb Croatia
Danish Commitee for Health Education Copenhagen East Denmark
Department of Allergy and Clinical Immunology Ajou University School of Medicine Suwon South Korea
Department of Allergy and Immunology Hospital Quirónsalud Bizkaia Erandio Spain
Department of Clinical Epidemiology and Biostatistics McMaster University Hamilton ON Canada
Department of Clinical Immunology Wrocław Medical University Wrocław Poland
Department of Clinical Pharmacy of Lithuanian University of Health Kaunas Lithuania
Department of Clinical Science and Education Södersjukhuset Karolinska Institutet Stockholm Sweden
Department of ENT Medical University of Graz Graz Austria
Department of Geriatrics Montpellier University hospital Montpellier France
Department of Health Social Services and Public Safety Belfast Northern Ireland UK
Department of Infection Immunity and Inflammation University of Leicester Leicester UK
Department of Internal Medicine Medical University of Graz Graz Austria
Department of Medicine and Surgery University of Salerno Baronissi Italy
Department of Medicine Bon Secours Hospital Glasnevin Dublin Ireland
Department of Medicine Clinical Immunology and Allergy McMaster University Hamilton ON Canada
Department of Medicine University of Cape Town Cape Town South Africa
Department of Nephrology and Endocrinology Karolinska University Hospital Stockholm Sweden
Department of Otorhinolaryngology Amsterdam University Medical Centres AMC Amsterdam The Netherlands
Department of Otorhinolaryngology University of Crete School of Medicine Heraklion Greece
Department of Paediatrics and Child Health Red Cross Children's Hospital Cape Town South Africa
Department of Paediatrics and Child Health University College Cork Cork Ireland
Department of Paediatrics Oslo University Hospital Oslo Norway
Department of Pediatrics Hospital Archbishop Makarios 3 Nicosia Cyprus
Department of Pharmacy University of Naples Federico 2 Naples Italy
Department of Public Health and Primary Care Leiden University Medical Center Leiden The Netherlands
Department of Pulmonary Diseases Celal Bayar University Faculty of Medicine Manisa Turkey
Department of Pulmonary Medicine CHU Sart Tilman and GIGA I3 Research Group Liege Belgium
Department of Pulmonary Medicine Rashid Hospital Dubai UAE
Department of Respiratory Medicine and Allergology University Hospital Lund Sweden
Department of Respiratory Medicine Hvidovre Hospital and University of Copenhagen Copenhagen Denmark
Department of Respiratory Medicine University Hospital Olomouc Olomouc Czech Republic
Dept of Otolaryngology Head and Neck Surgery University of Mainz Mainz Germany
Dept of Otolaryngology Nippon Medical School Tokyo Japan
Dept of Otorhinolaryngology Chiba University Hospital Chiba Japan
Dept of Otorhinolaryngology HNO Klinik Universitätsklinikum Düsseldorf Düsseldorf Germany
Dept of Otorhinolaryngology Univ Hospitals Leuven Louvain Belgium
Dept of Respiratory Medicine Ghent University Hospital Ghent Belgium
DG for Health and Social Care Scottish Government Edinburgh UK
Die Hautambulanz and Rothhaar Study Center Berlin Germany
Division of Allergy Asthma and Clinical Immunology Emek Medical Center Afula Israel
Division of Allergy Immunology University of South Florida Tampa FL USA
EA 2991 Euromov University Montpellier Montpellier France
EFA European Federation of Allergy and Airways Diseases Patients' Associations Brussels Belgium
EIP AHA Reference Site Coimbra Portugal
EIT Health France Paris France
ENT Department University Hospital of Kinshasa Kinshasa Congo
ERS President 2017 2018 Athens Chest Hospital 7th Resp Med Dept and Asthma Center Athens Greece
Eshelman School of Pharmacy University of North Carolina Chapel Hill NC USA
EUREGHA European Regional and Local Health Association Brussels Belgium
European Forum for Research and Education in Allergy and Airway Diseases Brussels Belgium
European Health Futures Forum Dromahair UK
Faculty of Medicine and Surgery University of Medicine La Valette Malta
Faculty of Medicine Institute of Clinical Medicine University of Oslo Oslo Norway
Faculty of Medicine Transylvania University Brasov Romania
Faculty of Medicine Vilnius University Vilnius Lithuania
Farmacias Holon Lisbon Portugal
Farmacie Dei Golfi Group Massa Lubrense Italy
FILHA Finnish Lung Association Helsinki Finland
GARD Chairman Geneva Switzerland
Global Allergy and Asthma Platform GAAPP Vienna Austria
Global Alliance against Chronic Respiratory Diseases Joensuu Finland
Hospital Civil de Guadalajara Dr Juan 1 Menchaca Guadalarara Mexico
Hospital de Clinicas University of Parana Paraná Brazil
Hospital of the Hospitaller Brothers in Buda Budapest Hungary
Immunology and Allergy Division Clinical Hospital University of Chile Santiago Chile
INSERM U1042 and CHU de Grenoble Grenoble France
Institute for Clinical Epidemiology and Biometry University of Wuerzburg Würzburg Germany
Institute of Environmental Medicine Karolinska Institutet Stockholm Sweden
Institute of Health Policy and Management iBMG Erasmus University Rotterdam The Netherlands
International Primary Care Respiratory Group IPCRG Aberdeen Scotland UK
iQ4U Consultants Ltd London UK
IRCCS Oasi Maria SS Troina Italy
ISGlobAL Centre for Research in Environmental Epidemiology Barcelona Spain
Johns Hopkins School of Medicine Baltimore MD USA
KYomed INNOV Montpellier France
Laboratoire HP2 Université Grenoble Alpes Grenoble France
Life and Health Sciences Research Institute School of Medicine University of Minho Braga Portugal
MACVIA France Fondation Partenariale FMC VIA LR CHU 34295 Montpellier Cedex 5 France
Maladies Infectieuses et immunitaires CHUL Quebec City QC Canada
Mattone Internazionale Program Veneto Region Italy
Medical Consulting Czarlewski Levallois France
Medical Faculty ENT Department Eskisehir Osmangazi University Eskisehir Turkey
Medical Faculty Skopje University Clinic of Pulmonology and Allergy Skopje Republic of Macedonia
Medicine Department Hôpital de la Malbaie Quebec city QC Canada
MedScript Ltd Paraparomu New Zealand
MRC Unit on Child and Adolescent Health University of Cape Town Cape Town South Africa
Municipality Pharmacy Sarno Italy
National Center for Disease Control and Public Health of Georgia Tbilisi Georgia
National Center of Expertise in Cognitive Stimulation Broca Hospital Paris France
National Heart and Lung Institute Royal Brompton Hospital and Imperial College London UK
National Hospital Organization Tokyo National Hospital Tokyo Japan
National Institute for Health and Welfare Helsinki Finland
National Institute of Pneumology M Nasta Bucharest Romania
Nova Southeastern University Fort Lauderdale FL USA
NRC Institute of Immunology FMBA of Russia Moscow Russia
Pediatric Allergy and Asthma Unit Hacettepe University School of Medicine Ankara Turkey
Pediatric Allergy and Immunology Unit Children's hospital Ain Shams University Cairo Egypt
ProAR Nucleo de Excelencia em Asma Federal University of Bahia Bahia Brazil
PT Government Associate Laboratory ICVS 3B's Braga Guimarães Portugal
Pulmonary Environmental Epidemiology Unit CNR Institute of Clinical Physiology Pisa Italy
Quebec Heart and Lung Institute Laval University Quebec City QC Canada
Regional Ministry of Health of Andalusia Seville Spain
Research in Real Life Cambridge UK
Rhinology Unit and Smell Clinic ENT Department Hospital Clínic Barcelona Spain
Sach's Children and Youth Hospital Södersjukhuset Stockholm Sweden
School of Medicine University J J Strossmayer Osijek Croatia
Scientific Centre of Children's Health under the Russian Academy of Medical Sciences Moscow Russia
Section of Allergy and Immunology Saint Louis University School of Medicine Saint Louis MO USA
Servicio de Alergia e Immunologia Clinica Santa Isabel Buenos Aires Argentina
Sidkkids Hospitala and Institute of Health Policy Management and Evaluation Toronto Canada
Skin and Allergy Hospital Helsinki University Hospital and University of Helsinki Helsinki Finland
SLaai Sociedad Latinoamericana de Allergia Asma e Immunologia Barranquilla Colombia
Sociedad Paraguaya de Alergia Asma e Inmunologia Asunción Paraguay
SOS Allergology and Clinical Immunology USL Toscana Centro Prato Italy
Swiss Institute of Allergy and Asthma Research University of Zurich Davos Switzerland
Sydney Local Health District Glebe NSW Australia
Syrian Private University Damascus Syria
Termofischer Scientific Uppsala Sweden
The Allergy and Asthma Institute Islamabad Pakistan
Tobacco Control Research Centre Iranian Anti Tobacco Association Tehran Iran
Ukrainian Medical Stomatological Academy Poltava Ukraine
Unit of Geriatric Immunoallergology University of Bari Medical School Bari Italy
Universidad Autónoma de Nuevo León San Nicolás de los Garza Mexico
Universidad Católica de Córdoba Córdoba Argentina
Universitat Pompeu Fabra Barcelona Spain
Universitätsmedizin der Johannes Gutenberg Universität Mainz Mainz Germany
University Clinic of Respiratory and Allergic Diseases Golnik Slovenia
University Hospital 'Sv Ivan Rilski' Sofia Bulgaria
University of Medicine and Pharmacy Hochiminh City Vietnam
Upper Airways Research Laboratory ENT Dept Ghent University Hospital Ghent Belgium
WHO GARD Planning Group Salvador Brazil
Woolcock Emphysema Centre Sydney Australia
Woolcock Institute of Medical Research University of Sydney Sydney Australia
See more in PubMed
Bousquet J, Anto JM, Sterk PJ, Adcock IM, Chung KF, Roca J, et al. Systems medicine and integrated care to combat chronic noncommunicable diseases. Genome Med. 2011;3(7):43. doi: 10.1186/gm259. PubMed DOI PMC
Stenberg K, Lauer JA, Gkountouras G, Fitzpatrick C, Stanciole A. Econometric estimation of WHO-CHOICE country-specific costs for inpatient and outpatient health service delivery. Cost Eff Resour Alloc. 2018;16:11. doi: 10.1186/s12962-018-0095-x. PubMed DOI PMC
Crespi-Lofton J, Skelton JB. The growing role of biologics and biosimilars in the United States: Perspectives from the APhA Biologics and Biosimilars Stakeholder Conference. J Am Pharm Assoc. 2017;57(5):e15–e27. doi: 10.1016/j.japh.2017.05.014. PubMed DOI
Gronde TV, Uyl-de Groot CA, Pieters T. Addressing the challenge of high-priced prescription drugs in the era of precision medicine: a systematic review of drug life cycles, therapeutic drug markets and regulatory frameworks. PLoS ONE. 2017;12(8):e0182613. doi: 10.1371/journal.pone.0182613. PubMed DOI PMC
Global Burden of Disease Health Financing Collaborator N Future and potential spending on health 2015–2040: development assistance for health, and government, prepaid private, and out-of-pocket health spending in 184 countries. Lancet. 2017;389(10083):2005–2030. doi: 10.1016/S0140-6736(17)30873-5. PubMed DOI PMC
Russell J, Greenhalgh T. Affordability as a discursive accomplishment in a changing National Health Service. Soc Sci Med. 2012;75(12):2463–2471. doi: 10.1016/j.socscimed.2012.09.026. PubMed DOI
Hunter DJ, Erskine J, Small A, McGovern T, Hicks C, Whitty P, et al. Doing transformational change in the English NHS in the context of “big bang” redisorganisation. J Health Organ Manag. 2015;29(1):10–24. doi: 10.1108/JHOM-01-2014-0019. PubMed DOI
Farmanova E, Bonneville L, Bouchard L. Organizational health literacy: review of theories, frameworks, guides, and implementation issues. Inquiry. 2018;55:46958018757848. PubMed PMC
Campbell H, Hotchkiss R, Bradshaw N, Porteous M. Integrated care pathways. BMJ. 1998;316(7125):133–137. doi: 10.1136/bmj.316.7125.133. PubMed DOI PMC
Hujala A, Taskinen H, Rissanen S. In: Richardson E, van Ginneken E, editors. How to support integration to promote care for people with multimorbidity in Europe? European Observatory Policy Briefs. Copenhagen (Denmark); 2017. PubMed
Palmer K, Marengoni A, Forjaz MJ, Jureviciene E, Laatikainen T, Mammarella F, et al. Multimorbidity care model: recommendations from the consensus meeting of the Joint Action on Chronic Diseases and Promoting Healthy Ageing across the Life Cycle (JA-CHRODIS) Health Policy. 2018;122(1):4–11. doi: 10.1016/j.healthpol.2017.09.006. PubMed DOI
Overill S. A practical guide to care pathways. J Integr Care. 1998;2:93–98. doi: 10.1177/146245679800200307. DOI
Chisholm-Burns MA, Kim Lee J, Spivey CA, Slack M, Herrier RN, Hall-Lipsy E, et al. US pharmacists’ effect as team members on patient care: systematic review and meta-analyses. Med Care. 2010;48(10):923–933. doi: 10.1097/MLR.0b013e3181e57962. PubMed DOI
Lee JK, Slack MK, Martin J, Ehrman C, Chisholm-Burns M. Geriatric patient care by U.S. pharmacists in healthcare teams: systematic review and meta-analyses. J Am Geriatr Soc. 2013;61(7):1119–1127. doi: 10.1111/jgs.12323. PubMed DOI
Skypala IJ, de Jong NW, Angier E, Gardner J, Kull I, Ryan D, et al. Promoting and achieving excellence in the delivery of Integrated Allergy Care: the European Academy of Allergy & Clinical Immunology competencies for allied health professionals working in allergy. Clin Transl Allergy. 2018;8:31. doi: 10.1186/s13601-018-0218-7. PubMed DOI PMC
Brozek JL, Bousquet J, Baena-Cagnani CE, Bonini S, Canonica GW, Casale TB, et al. Allergic Rhinitis and its Impact on Asthma (ARIA) guidelines: 2010 revision. J Allergy Clin Immunol. 2010;126(3):466–476. doi: 10.1016/j.jaci.2010.06.047. PubMed DOI
Brozek JL, Bousquet J, Agache I, Agarwal A, Bachert C, Bosnic-Anticevich S, et al. Allergic Rhinitis and its Impact on Asthma (ARIA) Guidelines—2016 revision. J Allergy Clin Immunol. 2017;140(4):950–958. doi: 10.1016/j.jaci.2017.03.050. PubMed DOI
Dykewicz MS, Wallace DV, Baroody F, Bernstein J, Craig T, Finegold I, et al. Treatment of seasonal allergic rhinitis: an evidence-based focused 2017 guideline update. Ann Allergy Asthma Immunol. 2017;119(6):489–511. doi: 10.1016/j.anai.2017.08.012. PubMed DOI
Bousquet J, Devillier P, Arnavielhe S, Bedbrook A, Alexis-Alexandre G, van Eerd M, et al. Treatment of allergic rhinitis using mobile technology with real-world data: The MASK observational pilot study. Allergy. 2018;73(9):1763–1774. doi: 10.1111/all.13406. PubMed DOI
Gray WN, Netz M, McConville A, Fedele D, Wagoner ST, Schaefer MR. Medication adherence in pediatric asthma: a systematic review of the literature. Pediatr Pulmonol. 2018;53(5):668–684. doi: 10.1002/ppul.23966. PubMed DOI
Bousquet J, Murray R, Price D, Somekh D, Munter L, Phillips J, et al. The allergic allergist behaves like a patient. Ann Allergy Asthma Immunol. 2018;121(6):741–742. doi: 10.1016/j.anai.2018.07.034. PubMed DOI
Bedard A, Basagana X, Anto JM, Garcia-Aymerich J, Devillier P, Arnavielhe S, et al. Mobile technology offers novel insights on control and treatment of allergic rhinitis. The MASK study. J Allergy Clin Immunol. 2019;144(1):135–143.e6. doi: 10.1016/j.jaci.2019.01.053. PubMed DOI
Bateman ED, Reddel HK, O’Byrne PM, Barnes PJ, Zhong N, Keen C, et al. As-needed budesonide–formoterol versus maintenance budesonide in mild asthma. N Engl J Med. 2018;378(20):1877–1887. doi: 10.1056/NEJMoa1715275. PubMed DOI
O’Byrne PM, FitzGerald JM, Bateman ED, Barnes PJ, Zhong N, Keen C, et al. Inhaled combined budesonide–formoterol as needed in mild asthma. N Engl J Med. 2018;378(20):1865–1876. doi: 10.1056/NEJMoa1715274. PubMed DOI
Camargos P, Affonso A, Calazans G, Ramalho L, Ribeiro ML, Jentzsch N, et al. On-demand intermittent beclomethasone is effective for mild asthma in Brazil. Clin Transl Allergy. 2018;8:7. doi: 10.1186/s13601-018-0192-0. PubMed DOI PMC
Levine DMSS, Squires A, Nicholson J, Jay M. Technology-assisted weight loss interventions in primary care: a systematic review. J Gen Intern Med. 2015;30(1):107–117. doi: 10.1007/s11606-014-2987-6. PubMed DOI PMC
Van der Roest HGWJ, Pastink C, Dröes RM, Orrell M. Assistive technology for memory support in dementia. Cochrane Database Syst Rev. 2017;6:CD009627. doi: 10.1002/14651858.cd009627. PubMed DOI PMC
Bhattarai PPJ. The role of digital health technologies in management of pain in older people: an integrative review. Arch Gerontol Geriatr. 2017;68:14–24. doi: 10.1016/j.archger.2016.08.008. PubMed DOI
Hui CY, Walton R, McKinstry B, Jackson T, Parker R, Pinnock H. The use of mobile applications to support self-management for people with asthma: a systematic review of controlled studies to identify features associated with clinical effectiveness and adherence. J Am Med Inform Assoc. 2017;24(3):619–632. PubMed PMC
Bousquet J, Hellings P, Agache I, Amat F, Annesi-Maesano I, Ansotegui I, et al. ARIA Phase 4 (2018): Change management in allergic rhinitis and asthma multimorbidity using mobile technology. J Allergy Clin Immunol 2018 (in press). PubMed
De Greve G, Hellings PW, Fokkens WJ, Pugin B, Steelant B, Seys SF. Endotype-driven treatment in chronic upper airway diseases. Clin Transl Allergy. 2017;7:22. doi: 10.1186/s13601-017-0157-8. PubMed DOI PMC
Vandenplas O, Vinnikov D, Blanc PD, Agache I, Bachert C, Bewick M, et al. Impact of rhinitis on work productivity: a systematic review. J Allergy Clin Immunol Pract. 2018;6(4):1274–1286. doi: 10.1016/j.jaip.2017.09.002. PubMed DOI
Amaral R, Fonseca JA, Jacinto T, Pereira AM, Malinovschi A, Janson C, et al. Having concomitant asthma phenotypes is common and independently relates to poor lung function in NHANES 2007–2012. Clin Transl Allergy. 2018;8:13. doi: 10.1186/s13601-018-0201-3. PubMed DOI PMC
Cingi C, Gevaert P, Mosges R, Rondon C, Hox V, Rudenko M, et al. Multi-morbidities of allergic rhinitis in adults: European Academy of Allergy and Clinical Immunology Task Force Report. Clin Transl Allergy. 2017;7:17. doi: 10.1186/s13601-017-0153-z. PubMed DOI PMC
Bousquet J, Van Cauwenberge P, Khaltaev N. Allergic rhinitis and its impact on asthma. J Allergy Clin Immunol. 2001;108(5 Suppl):S147–S334. doi: 10.1067/mai.2001.118891. PubMed DOI
Bousquet J, Khaltaev N, Cruz AA, Denburg J, Fokkens WJ, Togias A, et al. Allergic Rhinitis and its Impact on Asthma (ARIA) 2008 update (in collaboration with the World Health Organization, GA(2)LEN and AllerGen) Allergy. 2008;63(Suppl 86):8–160. doi: 10.1111/j.1398-9995.2007.01620.x. PubMed DOI
Bousquet J, Hellings PW, Agache I, Bedbrook A, Bachert C, Bergmann KC, et al. ARIA 2016: Care pathways implementing emerging technologies for predictive medicine in rhinitis and asthma across the life cycle. Clin Transl Allergy. 2016;6:47. doi: 10.1186/s13601-016-0137-4. PubMed DOI PMC
ARIA in the pharmacy: management of allergic rhinitis symptoms in the pharmacy. Allergic rhinitis and its impact on asthma. Allergy. 2004;59(4):373-87. PubMed
Carr WW, Yawn BP. Management of allergic rhinitis in the era of effective over-the-counter treatments. Postgrad Med. 2017;129(6):572–580. doi: 10.1080/00325481.2017.1333384. PubMed DOI
Lombardi C, Musicco E, Rastrelli F, Bettoncelli G, Passalacqua G, Canonica GW. The patient with rhinitis in the pharmacy. A cross-sectional study in real life. Asthma Res Pract. 2015;1(1):4. doi: 10.1186/s40733-015-0002-6. PubMed DOI PMC
Fromer LM, Blaiss MS, Jacob-Nara JA, Long RM, Mannion KM, Lauersen LA. Current Allergic Rhinitis Experiences Survey (CARES): Consumers’ awareness, attitudes and practices. Allergy Asthma Proc. 2014;35(4):307–315. doi: 10.2500/aap.2014.35.3766. PubMed DOI
Bousquet J, Neukirch F, Bousquet PJ, Gehano P, Klossek JM, Le Gal M, et al. Severity and impairment of allergic rhinitis in patients consulting in primary care. J Allergy Clin Immunol. 2006;117(1):158–162. doi: 10.1016/j.jaci.2005.09.047. PubMed DOI
Bousquet J, Annesi-Maesano I, Carat F, Leger D, Rugina M, Pribil C, et al. Characteristics of intermittent and persistent allergic rhinitis: DREAMS study group. Clin Exp Allergy. 2005;35(6):728–732. doi: 10.1111/j.1365-2222.2005.02274.x. PubMed DOI
Bousquet PJ, Devillier P, Tadmouri A, Mesbah K, Demoly P, Bousquet J. Clinical relevance of cluster analysis in phenotyping allergic rhinitis in a real-life study. Int Arch Allergy Immunol. 2015;166(3):231–240. doi: 10.1159/000381339. PubMed DOI
del Cuvillo A, Montoro J, Bartra J, Valero A, Ferrer M, Jauregui I, et al. Validation of ARIA duration and severity classifications in Spanish allergic rhinitis patients—the ADRIAL cohort study. Rhinology. 2010;48(2):201–205. PubMed
Jauregui I, Davila I, Sastre J, Bartra J, del Cuvillo A, Ferrer M, et al. Validation of ARIA (Allergic Rhinitis and its Impact on Asthma) classification in a pediatric population: the PEDRIAL study. Pediatr Allergy Immunol. 2011;22(4):388–392. doi: 10.1111/j.1399-3038.2010.01108.x. PubMed DOI
Adams K, Greiner A, JM JC. The 1st Annual Crossing the Quality Chasm Summit—a Focus on Communities Chapter 5. 2004. https://www.ncbi.nlm.nih.gov/books/NBK215507. PubMed
Richard A, Shea K. Delineation of self-care and associated concepts. J Nurs Scholarsh. 2011;43:255–264. PubMed
Silva DD. Helping people help themselves: a review of the evidence considering whether it is worthwhile to support self-management. The Health Foundation 2011. http://www.healthorguk/sites/health/files/HelpingPeopleHelpThemselvespdf. 2011.
Pearce G, Parke H, Pinnock H, Epiphaniou E, Bourne C, Sheikh A, et al. The PRISMS taxonomy of self-management support: derivation of a novel taxonomy and initial testing of utility. J Health Serv Res Policy. 2016;21:73–82. doi: 10.1177/1355819615602725. PubMed DOI
Pinnock H, Effing T, Bourbeau J, van-der-Palen J. Self-management of respiratory disease. Respipedia, the respiratory wiki. 2017. http://respipedia.ers-education.org/article/article/?idTopic=217. Accessed 29 Aug 2017.
Singh D, Ham C. A review of UK and international frameworks. http://www.improvingchroniccareorg/downloads/review_of_international_framework.
Bodenheimer T, Lorig K, Holman H, Grumbach K. Patient self-management of chronic disease in primary care. JAMA. 2002;288(19):2469–2475. doi: 10.1001/jama.288.19.2469. PubMed DOI
Hibbard J, Gilburt H. Supporting people to manage their health: an introduction to patient activation. King’s Fund 2014. 2014. https://www.kingsfund.org.uk/sites/files/kf/field/field_publication_file/supporting-people-manage-health-patient-activation-may14.pdf.
Mosen D, Schmittdiel J, Hibbard J, Sobel D, Remmers G, Bellows J. Is patient activation associated with outcomes of care for adults with chronic conditions? J Ambul Care Manag. 2007;30:21–29. doi: 10.1097/00004479-200701000-00005. PubMed DOI
Hellings PW, Borrelli D, Pietikainen S, Agache I, Akdis C, Bachert C, et al. European Summit on the Prevention and Self-Management of Chronic Respiratory Diseases: report of the European Union Parliament Summit (29 March 2017) Clin Transl Allergy. 2017;7:49. doi: 10.1186/s13601-017-0186-3. PubMed DOI PMC
Bousquet J, Anto JM, Annesi-Maesano I, Dedeu T, Dupas E, Pepin JL, et al. POLLAR: Impact of air POLLution on Asthma and Rhinitis; a European Institute of Innovation and Technology Health (EIT Health) project. Clin Transl Allergy. 2018;8:36. doi: 10.1186/s13601-018-0221-z. PubMed DOI PMC
Bousquet J, Chavannes NH, Guldemond N, Haahtela T, Hellings PW, Sheikh A. Realising the potential of mHealth to improve asthma and allergy care: how to shape the future. Eur Respir J. 2017 doi: 10.1183/13993003.00447-2017. PubMed DOI
Costa C, Menesatti P, Brighetti MA, Travaglini A, Rimatori V, Di Rienzo Businco A, et al. Pilot study on the short-term prediction of symptoms in children with hay fever monitored with e-Health technology. Eur Ann Allergy Clin Immunol. 2014;46(6):216–225. PubMed
Pizzulli A, Perna S, Florack J, Pizzulli A, Giordani P, Tripodi S, et al. The impact of telemonitoring on adherence to nasal corticosteroid treatment in children with seasonal allergic rhinoconjunctivitis. Clin Exp Allergy. 2014;44(10):1246–1254. doi: 10.1111/cea.12386. PubMed DOI
Bianchi A, Tsilochristou O, Gabrielli F, Tripodi S, Matricardi PM. The smartphone: a novel diagnostic tool in pollen allergy? J Investig Allergol Clin Immunol. 2016;26(3):204–207. doi: 10.18176/jiaci.0060. PubMed DOI
Huang X, Matricardi PM. Allergy and Asthma Care in the Mobile Phone Era. Clin Rev Allergy Immunol. 2016. PubMed
Bastl K, Berger U, Kmenta M. Evaluation of pollen apps forecasts: the need for quality control in an eHealth service. J Med Internet Res. 2017;19(5):e152. doi: 10.2196/jmir.7426. PubMed DOI PMC
Bousquet J, Arnavielhe S, Bedbrook A, Bewick M, Laune D, Mathieu-Dupas E, et al. MASK 2017: ARIA digitally-enabled, integrated, person-centred care for rhinitis and asthma multimorbidity using real-world-evidence. Clin Transl Allergy. 2018;8:45. doi: 10.1186/s13601-018-0227-6. PubMed DOI PMC
Samreth D, Arnavielhe S, Ingenrieth F, Bedbrook A, Onorato GL, Murray R, et al. Geolocation with respect to personal privacy for the Allergy Diary app—a MASK study. World Allergy Organ J. 2018;11(1):15. doi: 10.1186/s40413-018-0194-3. PubMed DOI PMC
Recital 26-EU GDPR. EU general data protection regulation 2016/679. http://www.privacy-regulation.eu/en/recital-26-GDPR.htm. Accessed 18 Aug 2019
Article 4 EU GDPR. « Definitions » . EU general data protection regulation 2016/679 (GDPR). http://www.privacy-regulation.eu/en/article-4-definitions-GDPR.htm. Accessed 18 Aug 2019
Sullivan PW, Nair KV, Patel BV. The effect of the Rx-to-OTC switch of loratadine and changes in prescription drug benefits on utilization and cost of therapy. Am J Manag Care. 2005;11(6):374–382. PubMed
Rachelefsky G, Farrar JR. Are you comfortable with over-the-counter intranasal steroids for children? A call to action. J Allergy Clin Immunol Pract. 2014;2(3):271–274. doi: 10.1016/j.jaip.2014.01.006. PubMed DOI
Carney AS, Price DB, Smith PK, Harvey R, Kritikos V, Bosnic-Anticevich SZ, et al. Seasonal patterns of oral antihistamine and intranasal corticosteroid purchases from Australian community pharmacies: a retrospective observational study. Pragmat Obs Res. 2017;8:157–165. doi: 10.2147/POR.S134266. PubMed DOI PMC
OTC fluticasone furoate nasal spray (Flonase Sensimist) for allergic rhinitis. Med Lett Drugs Ther. 2017;59(1519):e70-e1. PubMed
Porteous T, Wyke S, Smith S, Bond C, Francis J, Lee AJ, et al. ‘Help for Hay Fever’, a goal-focused intervention for people with intermittent allergic rhinitis, delivered in Scottish community pharmacies: study protocol for a pilot cluster randomized controlled trial. Trials. 2013;14:217. doi: 10.1186/1745-6215-14-217. PubMed DOI PMC
Walls RS, Heddle RJ, Tang ML, Basger BJ, Solley GO, Yeo GT. Optimising the management of allergic rhinitis: an Australian perspective. Med J Aust. 2005;182(1):28–33. PubMed
Smith L, Brown L, Saini B, Seeto C. Strategies for the management of intermittent allergic rhinitis: an Australian study. Health Expect. 2014;17(2):154–163. doi: 10.1111/j.1369-7625.2011.00746.x. PubMed DOI PMC
O’Connor J, Seeto C, Saini B, Bosnic-Anticevich S, Krass I, Armour C, et al. Healthcare professional versus patient goal setting in intermittent allergic rhinitis. Patient Educ Couns. 2008;70(1):111–117. doi: 10.1016/j.pec.2007.09.004. PubMed DOI
Smith L, Nguyen T, Seeto C, Saini B, Brown L. The role of non-clinicians in a goal setting model for the management of allergic rhinitis in community pharmacy settings. Patient Educ Couns. 2011;85(2):e26–e32. doi: 10.1016/j.pec.2010.10.003. PubMed DOI
Lourenco O, Calado S, Sa-Sousa A, Fonseca J. Evaluation of allergic rhinitis and asthma control in a Portuguese community pharmacy setting. J Manag Care Spec Pharm. 2014;20(5):513–522. PubMed PMC
Kuipers E, Wensing M, de Smet P, Teichert M. Self-management research of asthma and good drug use (SMARAGD study): a pilot trial. Int J Clin Pharm. 2017;39(4):888–896. doi: 10.1007/s11096-017-0495-6. PubMed DOI PMC
Canonica GW, Triggiani M, Senna G. 360 degree perspective on allergic rhinitis management in Italy: a survey of GPs, pharmacists and patients. Clin Mol Allergy. 2015;13:25. doi: 10.1186/s12948-015-0029-5. PubMed DOI PMC
Smith P, Price D, Harvey R, Carney AS, Kritikos V, Bosnic-Anticevich SZ, et al. Medication-related costs of rhinitis in Australia: a NostraData cross-sectional study of pharmacy purchases. J Asthma Allergy. 2017;10:153–161. doi: 10.2147/JAA.S128431. PubMed DOI PMC
Brozek JL, Akl EA, Alonso-Coello P, Lang D, Jaeschke R, Williams JW, et al. Grading quality of evidence and strength of recommendations in clinical practice guidelines. Part 1 of 3. An overview of the GRADE approach and grading quality of evidence about interventions. Allergy. 2009;64(5):669–677. doi: 10.1111/j.1398-9995.2009.01973.x. PubMed DOI
Brozek JL, Baena-Cagnani CE, Bonini S, Canonica GW, Rasi G, van Wijk RG, et al. Methodology for development of the Allergic Rhinitis and its Impact on Asthma guideline 2008 update. Allergy. 2008;63(1):38–46. doi: 10.1111/j.1398-9995.2007.01560.x. PubMed DOI
Padjas A, Kehar R, Aleem S, Mejza F, Bousquet J, Schunemann HJ, et al. Methodological rigor and reporting of clinical practice guidelines in patients with allergic rhinitis: QuGAR study. J Allergy Clin Immunol. 2014;133(3):777–783. doi: 10.1016/j.jaci.2013.08.029. PubMed DOI
Costa DJ, Amouyal M, Lambert P, Ryan D, Schunemann HJ, Daures JP, et al. How representative are clinical study patients with allergic rhinitis in primary care? J Allergy Clin Immunol. 2011;127(4):920–926. doi: 10.1016/j.jaci.2010.10.058. PubMed DOI
Parmelli E, Amato L, Oxman AD, Alonso-Coello P, Brunetti M, Moberg J, et al. Grade evidence to decision (EtD) framework for coverage decisions. Int J Technol Assess Health Care. 2017;33(2):176–182. doi: 10.1017/S0266462317000447. PubMed DOI
Schunemann HJ, Mustafa R, Brozek J, Santesso N, Alonso-Coello P, Guyatt G, et al. GRADE Guidelines: 16. GRADE evidence to decision frameworks for tests in clinical practice and public health. J Clin Epidemiol. 2016;76:89–98. doi: 10.1016/j.jclinepi.2016.01.032. PubMed DOI
Alonso-Coello P, Oxman AD, Moberg J, Brignardello-Petersen R, Akl EA, Davoli M, et al. GRADE Evidence to Decision (EtD) frameworks: a systematic and transparent approach to making well informed healthcare choices. 2: Clinical practice guidelines. BMJ. 2016;353:i2089. doi: 10.1136/bmj.i2089. PubMed DOI
Schunemann HJ, Hill SR, Kakad M, Vist GE, Bellamy R, Stockman L, et al. Transparent development of the WHO rapid advice guidelines. PLoS Med. 2007;4(5):e119. doi: 10.1371/journal.pmed.0040119. PubMed DOI PMC
Neumann I, Brignardello-Petersen R, Wiercioch W, Carrasco-Labra A, Cuello C, Akl E, et al. The GRADE evidence-to-decision framework: a report of its testing and application in 15 international guideline panels. Implement Sci. 2016;11:93. doi: 10.1186/s13012-016-0462-y. PubMed DOI PMC
update. BTSSIGNBGotMoAS. http://www.sign.ac.uk/sign-153-british-guideline-on-the-management-of-asthma.html. 2016.
Pinnock HEE, Pearce G, Parke HL, Greenhalgh T, Sheikh A, Griffiths CJ, Taylor SJC. Implementing supported self-management for asthma: a systematic review of implementation studies. BMC Med. 2015;13:127. doi: 10.1186/s12916-015-0361-0. PubMed DOI PMC
Bousquet J, Lund VJ, Van Cauwenberge P, Bremard-Oury C, Mounedji N, Stevens MT, et al. Implementation of guidelines for seasonal allergic rhinitis: a randomized controlled trial. Allergy. 2003;58(8):733–741. doi: 10.1034/j.1398-9995.2003.00076.x. PubMed DOI
Bousquet J, Bodez T, Gehano P, Klossek JM, Liard F, Neukirch F, et al. Implementation of guidelines for allergic rhinitis in specialist practices. A randomized pragmatic controlled trial. Int Arch Allergy Immunol. 2009;150(1):75–82. doi: 10.1159/000210383. PubMed DOI
Bousquet J, Schünemann H, Togias A, Bachert C, Erhola M, Hellings P, et al. Next-generation ARIA guidelines for allergic rhinitis based on GRADE and real-world evidence. J Allergy Clin Immunol. 2019 (in press). PubMed
Bachert C, Bousquet J, Hellings P. Rapid onset of action and reduced nasal hyperreactivity: new targets in allergic rhinitis management. Clin Transl Allergy. 2018;8:25. doi: 10.1186/s13601-018-0210-2. PubMed DOI PMC
Bousquet J, Hellings PW, Agache I, Amat F, Annesi-Maesano I, Ansotegui IJ, et al. ARIA Phase 4 (2018): Change management in allergic rhinitis and asthma multimorbidity using mobile technology. J Allergy Clin Immunol. 2018 doi: 10.1016/j.jaci.2018.08.049. PubMed DOI
Seys SF, Bousquet J, Bachert C, Fokkens WJ, Agache I, Bernal-Sprekelsen M, et al. mySinusitisCoach: patient empowerment in chronic rhinosinusitis using mobile technology. Rhinology. 2018;56(3):209–215. PubMed
Flandroy L, Poutahidis T, Berg G, Clarke G, Dao MC, Decaestecker E, et al. The impact of human activities and lifestyles on the interlinked microbiota and health of humans and of ecosystems. Sci Total Environ. 2018;627:1018–1038. doi: 10.1016/j.scitotenv.2018.01.288. PubMed DOI
Samolinski B, Fronczak A, Wlodarczyk A, Bousquet J. Council of the European Union conclusions on chronic respiratory diseases in children. Lancet. 2012;379(9822):e45–e46. doi: 10.1016/S0140-6736(12)60514-5. PubMed DOI
Bousquet J, Tanasescu CC, Camuzat T, Anto JM, Blasi F, Neou A, et al. Impact of early diagnosis and control of chronic respiratory diseases on active and healthy ageing. A debate at the European Union Parliament. Allergy. 2013;68(5):555–561. doi: 10.1111/all.12115. PubMed DOI
Bousquet J, Anto JM, Berkouk K, Gergen P, Antunes JP, Auge P, et al. Developmental determinants in non-communicable chronic diseases and ageing. Thorax. 2015;70(6):595–597. doi: 10.1136/thoraxjnl-2014-206304. PubMed DOI PMC
Bousquet J, Addis A, Adcock I, Agache I, Agusti A, Alonso A, et al. Integrated care pathways for airway diseases (AIRWAYS-ICPs) Eur Respir J. 2014;44(2):304–323. doi: 10.1183/09031936.00014614. PubMed DOI
Bousquet J, Michel J, Standberg T, Crooks G, Iakovidis I, Gomez M. The European Innovation Partnership on Active and Healthy Ageing: the European Geriatric Medicine introduces the EIP on AHA Column. Eur Geriatr Med. 2014;5(6):361–362. doi: 10.1016/j.eurger.2014.09.010. DOI
Bousquet J, Dahl R, Khaltaev N. Global alliance against chronic respiratory diseases. Allergy. 2007;62(3):216–223. doi: 10.1111/j.1398-9995.2007.01307.x. PubMed DOI
Bousquet J, Barbara C, Bateman E, Bel E, Bewick M, Chavannes NH, et al. AIRWAYS-ICPs (European Innovation Partnership on Active and Healthy Ageing) from concept to implementation. Eur Respir J. 2016;47(4):1028–1033. doi: 10.1183/13993003.01856-2015. PubMed DOI
Muraro A, Fokkens WJ, Pietikainen S, Borrelli D, Agache I, Bousquet J, et al. European Symposium on Precision Medicine in Allergy and Airways Diseases: report of the European Union Parliament Symposium (October 14, 2015) Allergy. 2016;71(5):583–587. doi: 10.1111/all.12819. PubMed DOI
Valiulis A, Bousquet J, Veryga A, Suprun U, Sergeenko D, Cebotari S, et al. Vilnius Declaration on chronic respiratory diseases: multisectoral care pathways embedding guided self-management, mHealth and air pollution in chronic respiratory diseases. Clin Transl Allergy. 2019;9:7. doi: 10.1186/s13601-019-0242-2. PubMed DOI PMC